Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBTF
1751
DELISTED
MBT Financial Corporation
MBTF
| $4.67M | 0.01% |
480,939
-28,508
| -6% | -$306K |
|
1752
Blue Bird Corp
BLBD
$2.05B
| $4.66M | 0.01% |
274,320
-14,880
| -5% | -$269K |
|
1753
OSI Systems
OSIS
$3.76B
| $4.66M | 0.01% |
+62,008
| New | +$4.69M |
|
1754
NRC Health Common Stock
NRC
$469M
| $4.66M | 0.01% |
173,200
+34,800
| +25% | +$851K |
|
1755
Civista Bancshares
CIVB
$593M
| $4.65M | 0.01% |
222,800
+13,500
| +6% | +$284K |
|
1756
Kohl's
KSS
$2.18B
| $4.63M | 0.01% |
+119,700
| New | +$4.59M |
|
|
QTS
1757
DELISTED
QTS REALTY TRUST, INC.
QTS
| $4.63M | 0.01% |
88,400
+70,600
| +397% | +$3.66M |
|
|
LMOS
1758
DELISTED
Lumos Networks Corp
LMOS
| $4.63M | 0.01% |
258,800
-591,700
| -70% | -$10.6M |
|
1759
Matsons
MATX
$6.5B
| $4.62M | 0.01% |
153,700
+90,200
| +142% | +$2.76M |
|
1760
Natural Alternatives International
NAII
$12.8M
| $4.61M | 0.01% |
463,200
-13,700
| -3% | -$136K |
|
1761
Telefônica Brasil
VIV
$18.2B
| $4.59M | 0.01% |
+340,553
| New | +$4.9M |
|
1762
Mine Safety
MSA
$7.3B
| $4.59M | 0.01% |
56,500
+30,826
| +120% | +$2.39M |
|
|
CNBKA
1763
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $4.58M | 0.01% |
72,038
+19,138
| +36% | +$1.2M |
|
|
BKS
1764
DELISTED
Barnes & Noble
BKS
| $4.57M | 0.01% |
601,700
+300,597
| +100% | +$2.36M |
|
1765
Northern Trust
NTRS
$35B
| $4.57M | 0.01% |
+46,998
| New | +$4.23M |
|
1766
Aware
AWRE
$26.4M
| $4.55M | 0.01% |
883,800
-15,087
| -2% | -$72.1K |
|
|
ALSK
1767
DELISTED
Alaska Communications Systems
ALSK
| $4.55M | 0.01% |
2,066,840
+283,700
| +16% | +$619K |
|
|
LBY
1768
DELISTED
Libbey, Inc.
LBY
| $4.55M | 0.01% |
564,200
+103,913
| +23% | +$1.01M |
|
|
CDI
1769
DELISTED
CDI Corp.
CDI
| $4.54M | 0.01% |
776,100
+31,800
| +4% | +$219K |
|
|
LQ
1770
DELISTED
La Quinta Holdings Inc.
LQ
| $4.54M | 0.01% |
307,300
-634,700
| -67% | -$8.96M |
|
1771
Lifetime Brands
LCUT
$226M
| $4.53M | 0.01% |
249,800
+36,700
| +17% | +$700K |
|
|
MTGE
1772
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $4.53M | 0.01% |
241,100
+67,307
| +39% | +$1.22M |
|
1773
Primoris Services
PRIM
$4.48B
| $4.53M | 0.01% |
181,600
+14,800
| +9% | +$350K |
|
|
ABCO
1774
DELISTED
Advisory Board Co
ABCO
| $4.52M | 0.01% |
+87,801
| New | +$4.4M |
|
|
TRK
1775
DELISTED
Speedway Motorsports, Inc.
TRK
| $4.52M | 0.01% |
247,400
-25,800
| -9% | -$470K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.